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Pseudo Hyperphosphatemia in Multiple Myeloma
Anshul Kumar, Pradeep Dhakarwal, Vibha Agrawal, Tayyab Ali, Nephrology Division
Lehigh Valley Health Network, Allentown, Pennsylvania

BACKGROUND:
Hyperphosphatemia is a common condition found
in patients with decreased kidney function. Without
treatment, it can lead to a variety of clinical
consequences. The presence of hyperphosphatemia
in patients with normal kidney function may be
true or spurious. We present a case of pseudo
hyperphosphatemia in a patient with multiple myeloma.

CASE REPORT:
60 year female with a history of Multiple myeloma in
remission was admitted with back pain. She was noted
to have sodium of 128mmol/l, phosphorus of 12.6mg/dl,
calcium 9mg/dl and creatinine of 1mg/dl by labs done
with Siemens Advia through spectrophotometry. She had
no clinical manifestations of hyperphosphatemia and her
serum osmolality was found to be normal. With normal
creatinine, calcium, low sodium and normal osmolality we
had suspicion of spurious results from paraproteinemia.
So, same sample was rechecked on dry chemistry
analyzer (Vitros). Barium sulfate spreading layer in the
Vitros dry chemistry slide filters the protein in serum
and assays phosphate in a protein free filtrate negating
interference of paraproteins. Patients repeat sodium and
phosphorus on the same blood sample was 137mmol/l
and 4.8mg/dl.

DISCUSSION:
Spurious elevation of the serum phosphorus
level may occur in with prolonged refrigeration,
prolonged exposure to room temperature, hemolysis,
hyperlipidemia, hyperbilirubinemia or paraproteinemia.
Ourpatient’s initial sample was tested using a clinical
analyzer in which inorganic phosphorus reacts with
ammonium molybdate in the presence of sulfuric
acidto form an unreduced phosphomolybdate complex.
This phosphomolybdate complex absorbs light and
is quantified photometrically in the UV range at a
wavelength of 340 nm. Light absorbance is directly
proportional to the inorganic phosphorus concentration.
Two mechanisms have been hypothesized to explain
pseudohyperphosphatemia. First, paraproteins bind to

molybdate, resulting in turbidity. The turbid reactionmixture
scatters and absorbs light while reducing its transmittance.
This then can be interpreted as a falsely high phosphorus
level. The second proposed mechanism for spurious
hyperphosphatemia is the direct binding of paraprotein
to phosphorus. This interference is seen with the liquid
colorimetric assay on the Advia is not seen with the slidebased, solid-state colorimetric assays on the Vitros In our
case, spurious hyperphosphatemia caused by hemolysis,
hyperlipidemia and hyperbilirubinemia was excluded.

RESULT:
Pseudohyperphosphatemia in the presence of serum
paraproteins has been documented but the paucity of
case reports reflect the scant attention clinicians routinely
pay to phosphate measurements. Clinicians taking
care of patients with myeloma need to be aware of the
potential interference in phosphate-measuring assays
that can result in spurious values to prevent unnecessary
tests and starting the patient on a phosphate binder
which can lead to dangerously low levels of phosphorus
with spurious normal readings.
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